CTCs of at least two NSCLC patients shared variants in six oncogenes/tumor suppressor genes: NF1, TP53, SMARCB1, SMAD4, KRAS, and ERBB2. This evidence concerns the gene ERBB2 and non-small cell lung carcinoma.